<?xml version="1.0" encoding="UTF-8"?>
<p id="par0265">The second part of the guideline was prepared for the patients who will receive convalescent plasma therapy. In this section, indications for the clinical use of convalescent plasma were defined and the order form for the request of blood products was created. In order to follow-up the patients treated with convalescent plasma in universal “Convalescent Plasma Treatment and Follow-up Care Report Form” was created. These forms are filled by clinicians for each patient and submitted to the Turkish Ministry of Health via web-based information system to enable to evaluate the effectiveness of convalescent plasma therapy by the authority. This follow-up process is thought to be crucial for the creation and development of current and future treatment modalities.</p>
